Australian industry welcomes PBS listing but Pradaxa concerns linger
This article was originally published in Scrip
Executive Summary
Australia's health ministry has announced the reimbursement listing of nine drugs under the state-funded Pharmaceutical Benefits Scheme (PBS), including AstraZeneca's platelet anti-aggregant Brilinta (ticagrelor).